Coactivator-associated arginine methyltransferase 1 (CARM1), a type I PRMTs, is deregulated in numerous cancers and plays critical roles in cancer progression by catalyzing asymmetric di-methylation of histone or nonhistone substrate proteins [9]. The gene discussed is CARM1; the disease is cancer.